talazoparib,enzalutamide
astellas,pfizer
['gu ', 'talapro-2', 'enzalutamide', 'pcsm', 'prostate', 'talazo', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'enzalu']
adding talazoparib to first-line treatment with enzalutamide improves radiographic progression-free survival in patients with metastatic castration-resistant prostate cancer, results of the talapro-2 trial suggest. presented at asco gu 2023. #gu23 #pcsm 
https://t.co/bi63MIVP5D is a resource offering oncology health care professionals practical information about the changing clinical landscape.